High-Dose Flu Shot Alzheimer's Risk: What Seniors Need to Know in 2026

# High-Dose Flu Shot Alzheimer's Risk: What Seniors Need to Know in 2026

> **Quick answer:** A April 2026 study in *Neurology* found that seniors who received the high-dose flu vaccine had up to 55% lower risk of developing Alzheimer's disease compared to those who got the standard-dose shot, in a study of roughly 165,000 adults aged 65 and older. The CDC already recommends the high-dose vaccine for everyone over 65 — but many seniors are still getting the standard dose without knowing the difference matters this much.

High dose flu shot Alzheimer's risk reduction is no longer just a hypothesis — a landmark study published April 8, 2026 in the journal *Neurology* has given the strongest evidence yet that upgrading to the high-dose flu vaccine at 65 may meaningfully protect the aging brain. If you or a senior family member still gets whichever flu shot is most convenient, it is time to pay closer attention to which one it is.

## The Study: What Researchers Found

The research was led by scientists at McGovern Medical School at UTHealth Houston and analyzed US insurance claims data from roughly 165,000 adults aged 65 and older. Participants had received either the high-dose inactivated influenza vaccine (H-IIV) — most commonly Fluzone High-Dose — or the standard-dose flu vaccine (S-IIV) over several flu seasons.

Using a "target trial emulation" design — a rigorous methodology that uses observational data to approximate the structure of a randomized clinical trial — researchers tracked Alzheimer's diagnoses over a follow-up window of approximately two years.